4ELLIOTT W J. Cyclic and circadian variations in cardiovascular events [ J ]. American Journal of Hypertension,2001,14(9) :291 -295.
5WEBER M A, FODERA S M. Circadian variations in cardiovascular diseases chronotherapeutic approaches to the management of hypertension[J]. Rev Cardiovase Med,2004,5(3) :148 - 155.
6BUSSEMER T, OTTO I, BODMEIER R. Pulsatile drug-delivery systems [J]. Crit Rev Ther Drug Cartier Syst ,2001,18 ( 5 ) :433 - 458.
7ROSS A C, MACRAE R J drug delivery from a pulsatile capsule device based on programmable erosion [J]. J Pharm pharmacol, 2000, 52(4) :903 -909.
8KUKIN M. L,MANNINO M. M,FREUq)ENBERGER R. S,et al. Hemodynamic comparison of twice daily Metoprolol Tartrate with once daily Metoprol- ol spccinate in congestive heart failure. Journal of the American College of Cardiology[J]. 2000,35( 1 ) :45-50.
9国家基本药物目录[M].北京:中国医药科技出版社,2013.
10JAMES E. Polli, G. Singh Rekhi, LARRY L Augsburger, et al. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets[ J]. Journal of Pharmaceutical Sciences, 1997,86 ( 6 ) :690.
